Bristol-Myers Squibb

(Image: Getty/Seb_Ra)

BMS-Celgene mega-merger receives shareholder nod

By Ben Hargreaves

The $74bn deal appeared to be fraying around edges, as certain shareholders voiced dissent, but a vote saw the deal pass with support from more than 75% of investors.

(Image: Getty/marchmeena29)

Hired and Retired: Summer Edition

By Ben Hargreaves

in-PharmaTechnologist gives you an overview of some of the notable hires that have taken place in the last month.

People on the Move

People on the Move

People on the Move

By Fiona Barry

Former employees of Procter & Gamble, Merck & Co. and Bristol Myers Squibb have all found new homes in the pharma industry in this week's People column.